The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/500 - 1/1000. Detects a band of approximately 61 kDa (predicted molecular weight: 61 kDa).
機能Assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
関連疾患Defects in CD19 are the cause of immunodeficiency common variable type 3 (CVID3) [MIM:613493]; also called antibody deficiency due to CD19 defect. CVID3 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B cells is usually in the normal range, but can be low.
Antibody deficiency due to defect in CD19, included antibody
B lymphocyte antigen CD19 antibody
B lymphocyte surface antigen B4 antibody
B-lymphocyte antigen CD19 antibody
B-lymphocyte surface antigen B4 antibody
CD19 antigen antibody
CD19 molecule antibody
Cd19 protein antibody
Differentiation antigen CD19 antibody
Leu 12 antibody
T-cell surface antigen Leu-12 antibody
Anti-CD19 antibody 画像
Western blot - CD19 antibody (ab63534)
All lanes : Anti-CD19 antibody (ab63534) at 1/500 dilution
Lane 1 : Extracts from COS7 cells (5ug-30ug of total protein), treated
with Serum (10%, 30mins), without immunising peptide Lane 2 : Extracts from COS7 cells (5ug-30ug of total protein), treated
with Serum (10%, 30mins), with immunising peptide (5-10ug)
Predicted band size : 61 kDa Observed band size : 61 kDa
Anti-CD19 antibody (ab63534) 使用論文
has not yet been referenced specifically in any publications.